Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 8-K, filed Sep 9, 2026
- Incorporated
- Delaware
- Filings on record
- 787 filings
- On EDGAR
- CIK 1422143
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 72
News 8 of 151
Prospectuses and Registrations 8 of 67
- S-8 Registration statement for an employee plan Jun 4, 2026
- S-8 Registration statement for an employee plan Nov 4, 2025
- S-8 Registration statement for an employee plan Jun 6, 2025
- S-8 Registration statement for an employee plan Feb 28, 2025
- S-8 Registration statement for an employee plan Jun 7, 2024
- S-8 Registration statement for an employee plan Feb 27, 2024
- 424B3 Prospectus supplement for an offering Feb 15, 2024
- S-3 Shelf registration statement Feb 9, 2024
Proxies 8 of 25
- DEFA14A Extra proxy material May 26, 2026
- DEFA14A Extra proxy material Apr 10, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2026
- DEFA14A Extra proxy material Apr 11, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 11, 2025
- DEFA14A Extra proxy material Apr 12, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 12, 2024
- DEFA14A Extra proxy material May 4, 2023
Ownership 8 of 414
- 4 Insider reported a trade Aug 24, 2026
- 4 Insider reported a trade Aug 24, 2026
- 144 Notice of a proposed sale of restricted stock Aug 21, 2026
- 4 Insider reported a trade Aug 21, 2026
- 144 Notice of a proposed sale of restricted stock Aug 19, 2026
- 4 Insider reported a trade Aug 17, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Jun 22, 2026
Other 8 of 58
- ARS Annual report sent to shareholders Apr 10, 2026
- ARS Annual report sent to shareholders Apr 17, 2025
- ARS Annual report sent to shareholders Apr 18, 2024
- UPLOAD Comment letter from SEC staff Feb 29, 2024
- EFFECT Notice that a registration became effective Feb 14, 2024
- CORRESP Reply to SEC staff Feb 14, 2024
- CORRESP Reply to SEC staff Feb 13, 2024
- D Feb 5, 2024
Everything here comes from Kura Oncology, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.